Literature DB >> 16627379

Contributions of fasting and postprandial glucose to hemoglobin A1c.

Louis Monnier1, Claude Colette.   

Abstract

OBJECTIVE: To define the respective contributions of fasting and postprandial plasma glucose to hemoglobin A1c (HbA1c) in patients with non-insulin-treated type 2 diabetes.
METHODS: Previous studies of diurnal glycemic profiles are reviewed, and glucose values for predicting successful treatment of diabetes are suggested.
RESULTS: By analyzing the results from prior studies of diurnal glycemic profiles, we found that the relative contribution of postprandial plasma glucose was high (70%) in patients with fairly good control of diabetes (HbA1c <7.3%) and decreased progressively (30%) with worsening diabetes (HbA1c >10.2%). In contrast, the contribution of fasting plasma glucose showed a gradual increase with increasing levels of HbA1c. By using the same model (the diurnal glycemic profile), we established that post-meal glycemia was a better predictor of good or satisfactory control of diabetes (HbA1c <7%) than was fasting glucose. The best cutoff values that ensured the optimal balance between high sensitivity and specificity were approximately 200 mg/dL at 11 AM and 160 mg/dL at 2 PM. The cut-point values for predicting treatment success (specificity (3) 90%) were 162 mg/dL at 11 AM and 126 mg/dL at 2 PM.
CONCLUSION: Postprandial plasma glucose is the predominant contributor in patients with satisfactory to good control of diabetes, whereas the contribution of fasting plasma glucose increases with worsening diabetes. Postmeal thresholds for predicting good or satisfactory control of diabetes are dependent on the timing of the meals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16627379     DOI: 10.4158/EP.12.S1.42

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  33 in total

Review 1.  Glycemic control and weight reduction without causing hypoglycemia: the case for continued safe aggressive care of patients with type 2 diabetes mellitus and avoidance of therapeutic inertia.

Authors:  Stanley S Schwartz; Benjamin A Kohl
Journal:  Mayo Clin Proc       Date:  2010-11-24       Impact factor: 7.616

2.  The continuous glucose monitoring system is effective in determining major factors affecting postprandial glycemic patterns in people with type 2 diabetes.

Authors:  Tomasz Klupa; Maciej T Małecki; Jacek Sieradzki
Journal:  J Diabetes Sci Technol       Date:  2008-05

Review 3.  Overbasalization: Addressing Hesitancy in Treatment Intensification Beyond Basal Insulin.

Authors:  Kevin Cowart
Journal:  Clin Diabetes       Date:  2020-07

4.  A defined, plant-based diet utilized in an outpatient cardiovascular clinic effectively treats hypercholesterolemia and hypertension and reduces medications.

Authors:  Rami S Najjar; Carolyn E Moore; Baxter D Montgomery
Journal:  Clin Cardiol       Date:  2018-03-25       Impact factor: 2.882

Review 5.  Relationship of insulin dose, A1c lowering, and weight in type 2 diabetes: comparing insulin glargine and insulin detemir.

Authors:  George Dailey; Karim Admane; Florence Mercier; David Owens
Journal:  Diabetes Technol Ther       Date:  2010-12       Impact factor: 6.118

6.  Implications of the Hemoglobin Glycation Index on the Diagnosis of Prediabetes and Diabetes.

Authors:  Daniel S Hsia; Neda Rasouli; Anastassios G Pittas; Christine W Lary; Anne Peters; Michael R Lewis; Sangeeta R Kashyap; Karen C Johnson; Erin S LeBlanc; Lawrence S Phillips; James M Hempe; Cyrus V Desouza
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

7.  No effect of insulin pen with memory function on glycemic control in a patient cohort with poorly controlled type 1 diabetes: a randomized open-label study.

Authors:  Thomas Danne; Thomas Forst; Jürgen Deinhard; Ludger Rose; Elisabeth Moennig; Axel Haupt
Journal:  J Diabetes Sci Technol       Date:  2012-11-01

8.  Importance of Postprandial Glucose in Relation to A1C and Cardiovascular Disease.

Authors:  Kenneth S Hershon; Barbara R Hirsch; Ola Odugbesan
Journal:  Clin Diabetes       Date:  2019-07

9.  Glucose meters with built-in automated bolus calculator: gadget or real value for insulin-treated diabetic patients?

Authors:  Ides M Colin; Isabelle Paris
Journal:  Diabetes Ther       Date:  2012-12-19       Impact factor: 2.945

Review 10.  Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes.

Authors:  Rehan Qayyum; Shari Bolen; Nisa Maruthur; Leonard Feldman; Lisa M Wilson; Spyridon S Marinopoulos; Padmini Ranasinghe; Muhammed Amer; Eric B Bass
Journal:  Ann Intern Med       Date:  2008-09-15       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.